US Patent 11084883 Specifically purified anti-presepsin antibody
Patent 11084883 was granted and assigned to Mochida Pharmaceutical on August, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+429 characters)
Article
Patent abstract
The present invention provides anti-presepsin polyclonal antibodies specifically binding to a peptide comprising an amino acid sequence of SEQ ID NO: 1. As a result, anti-presepsin polyclonal antibodies which have less variation in measured values between lot-to-lot differences of antibodies compared to S68 antibodies and thus suitable anti-presepsin polyclonal antibodies for presepsin measurement are provided.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Kamon Shirakawa0
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
110848830
Date of Patent
August 10, 2021
0Patent Application Number
201508250
Date Filed
August 25, 2015
0Official Website
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Oct, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11084883 Specifically purified anti-presepsin antibody
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11084883
Date of patent
August 10, 2021
Patent application number
20150825
Date Filed
August 25, 2015
Find more entities like US Patent 11084883 Specifically purified anti-presepsin antibody
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
